ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen
Year: 2017
Type: review
Source: Current Atherosclerosis Reports
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: apolipoprotein C-III, volanesorsen, antisense oligonucleotides, severe hypertriglyceridemia, familial chylomicronemia syndrome, triglyceride-rich lipoproteins, lipoprotein lipase inhibition, hepatic lipase, atherosclerosis, coronary artery disease, cardiometabolic syndrome, type 2 diabetes, lipid-lowering therapy, endothelial dysfunction, LDL cholesterol
Open Access status: closed
OpenAlex ID: W2767439026
